Product image of Mirvaso (Brimonidine Tartrate) supplied by GNH India

Mirvaso

Active Ingredient:
Brimonidine Tartrate
Origin:
EU

Mirvaso (Brimonidine Tartrate)

Brimonidine tartrate, the active ingredient in Mirvaso, is an alpha‑2 adrenergic agonist presented as a topical gel for topical use. It selectively constricts cutaneous blood vessels, helping to reduce facial erythema in adults with rosacea. It is indicated for the treatment of persistent facial redness and is approved for use in the European Union.

GNH India supplies Mirvaso as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this prescription‑only product.

Manufacturer / TM Owner

Galderma International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mirvaso (brimonidine tartrate) is a topical vasoconstrictor used in the management of rosacea‑related facial erythema.

  • Facial erythema of rosacea: reduces persistent redness.
  • Rosacea‑related flushing: diminishes visible blood‑vessel dilation.
  • Post‑inflammatory erythema in rosacea: improves skin tone.

How It Works

  • Brimonidine tartrate acts as a selective alpha‑2 adrenergic receptor agonist on cutaneous blood vessels. Activation of these receptors triggers intracellular signaling that leads to vasoconstriction, thereby decreasing blood flow to the superficial dermal plexus and reducing the visible redness associated with rosacea.

Side Effects

Common Side Effects

  • Skin irritation: mild redness or discomfort at the application site.
  • Burning or stinging sensation.
  • Dryness of the treated area.
  • Pruritus (itching).
  • Erythema (localized redness).
  • Flushing.

Serious or Rare Side Effects

  • Allergic contact dermatitis.
  • Severe skin ulceration.
  • Worsening of rosacea symptoms.
  • Systemic hypotension from extensive absorption.
  • Ocular irritation if applied near the eyes.
  • Anaphylactic reaction (rare).

Precautions & Warnings

Mirvaso should be applied only to intact facial skin and avoided on mucous membranes.

  • Pregnancy: insufficient data; use only if clearly needed.
  • Breastfeeding: unknown safety; consider risk vs benefit.
  • Concomitant use with other topical vasoconstrictors may increase local irritation.
  • Avoid applying to broken or inflamed skin.
  • Discontinue if severe irritation or allergic reaction occurs.
  • Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Mirvaso may interact with other agents that affect vascular tone or skin integrity.

Major Interactions (Avoid)

  • Concurrent use of other topical alpha‑2 agonists (e.g., clonidine gel).
  • Systemic alpha‑2 agonists such as clonidine or guanfacine.

Moderate Interactions (Monitor Closely)

  • Topical irritants or exfoliants applied to the same area.
  • Alcohol‑based skin products that may increase irritation.
  • Other vasoconstrictive agents (e.g., phenylephrine) applied nearby.

Frequently Asked Questions

Mirvaso is a prescription‑only topical gel containing brimonidine tartrate that is used to reduce persistent facial redness (erythema) associated with rosacea in adult patients.

Brimonidine tartrate selectively activates alpha‑2 adrenergic receptors on cutaneous blood vessels, causing vasoconstriction. This reduces blood flow to the superficial dermal plexus and diminishes the visible redness of rosacea.

The prescribed dose of Mirvaso is determined by the treating clinician. Typically, a thin layer is applied once daily to the affected facial areas, but exact instructions should follow the prescriber’s order.

Safety data for Mirvaso in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a healthcare professional.

Enquiries for Mirvaso are submitted via the product page on gnhindia.com. Provide the required quantity, and GNH India will verify institutional credentials, then respond with pricing, availability, shipping details and any necessary import documentation.

Mirvaso is a topical vasoconstrictor, whereas many other rosacea agents, such as metronidazole or azelaic acid, act as anti‑inflammatory or antimicrobial agents. Mirvaso specifically targets facial erythema through vascular constriction, offering a complementary mechanism.

Mirvaso should be stored at room temperature, below 25 °C, in its original packaging. Protect the gel from moisture, excessive heat and direct sunlight to maintain its stability.

The gel is applied topically to clean, dry facial skin. A thin layer is spread over the affected areas once daily, usually in the morning, unless otherwise directed by the prescriber.

Serious risks include severe allergic reactions such as contact dermatitis, systemic hypotension from extensive absorption, and worsening of rosacea symptoms. Patients should discontinue use and seek medical attention if these occur.

Mirvaso should not be used on broken, inflamed or infected skin, in patients with known hypersensitivity to brimonidine or any excipients, and it is contraindicated in individuals using other topical alpha‑2 agonists concurrently.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brimonidine Tartrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT